ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
University Medical Centre Mannheim at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University Medical Centre Mannheim takes part in 4 sessions at ESMO 2026 in Madrid. Its work addresses immunotherapy and treatment of desmoid tumours. It includes a phase 3 study of varegacestat and examination of changes in tumour signal on T2-weighted imaging.
| Organization | ESMO 2026 Attendance |
|---|---|
University Medical Centre Mannheim Mannheim, Germany | |
Teaching hospital of Heidelberg University's medical faculty in Mannheim, Germany. | Chair Fri Oct 23 13:30–14:15 Liquid biopsies in advanced lung cancer: The future has arrived? Lung & thoracic cancers Talk Sun Oct 25 15:45–16:05 Gender differences in response to immuno-oncology therapies Nursing & supportive care Poster Mon Oct 26 12:00–12:45 RINGSIDE phase 3 study of varegacestat in desmoid tumors: Primary results and T2-weighted signal intensity changes Sarcoma, CNS, head & neck and rare cancers Satellite Mon Oct 26 13:00–14:30 Merck Healthcare KGaA - CARE FOR RARE: Desmoid Tumours in Clinical Practice − Shifting Strategies & Evolving Perspectives Sarcoma, CNS, head & neck and rare cancers Satellite Mon Oct 26 13:05–13:25 Introducing desmoid tumours (DTs): Disease, guidelines & therapy Sarcoma, CNS, head & neck and rare cancers Satellite Mon Oct 26 14:28–14:30 Close Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at University Medical Centre Mannheim
Tell us what you sell and we’ll find the people at University Medical Centre Mannheim most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction